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Prognostic value of MRI in arthroscopic
treatment of chronic patellar tendinopathy:
a prospective cohort study
Peter Ogon1, Kaywan Izadpanah2, Helge Eberbach2, Gernot Lang2, Norbert P. Südkamp2 and Dirk Maier2*
Background: To date, prognostic outcome factors for patients undergoing arthroscopic treatment due to chronic
patellar tendinopathy (PT) are lacking. The purpose of this study was to investigate whether preoperatively assessed
MRI parameters might be of prognostic value for prediction of functional outcome and return to sports in arthroscopic
treatment of chronic PT.
Methods: A prospective cohort study was conducted including 30 cases (4 female and 24 male competitive athletes)
undergoing arthroscopic patellar release (APR) due to chronic PT. The mean age was 28.2 years (range, 18–49 years) at
the time of surgery, and the mean follow-up period was 4.2 years (range, 2.2–10.4 years). Preoperatively assessed MRI
parameters included bone marrow edema (BME) of the inferior patellar pole, patellar tendon thickening, infrapatellar
fat pad (IFP) edema, and infrapatellar bursitis. Prevalences of preoperative MRI findings were correlated to functional
outcome scores in order to determine statistically significant predictors.
Results: All athletes regained their preinjury sports levels. Athletes featuring preoperative IFP edema showed significantly
inferior modified Blazina score (0.6 ± 0.7 vs. 0.2 ± 0.5), single assessment numeric evaluation (SANE; 86.0 ± 8.8 vs. 94.3 ± 7.5),
and Visual Analogue Scale (VAS; 1.0 ± 1.2 vs. 0.3 ± 0.8) compared to subjects without IFP edema (p < 0.05). Return to sports
required a mean of 4 ± 3.2 months. On average, patients with IFP edema needed significantly more time to return to
sports than subjects without IFP edema (6.5 vs 2.8 months; p < 0.05). The simultaneous presence of BME and IFP edema
was associated with significantly inferior outcomes by means of the Victorian Institute of Sport Assessment questionnaire
for patients with patellar tendinopathy (VISA-P; 88.1 ± 11.9 vs. 98.6 ± 4.2), SANE (84.3 ± 10.2 vs. 93.1 ± 8.3), and VAS (1.3 ± 1.
4 vs. 0.3 ± 0.9) compared to an isolated BME or isolated IFP edema.
Conclusions: This is the first study identifying prognostic outcome factors in arthroscopic treatment of chronic PT.
Preoperative IFP edema alone or simultaneous BME and IFP edema on preoperative MRI were associated with inferior
functional outcome and delayed return to sports. Knowledge of these predictive factors might improve risk stratification,
individualize treatment and postoperative rehabilitation, and contribute to improve clinical outcome. Moreover, current
findings offer the potential for novel therapeutic approaches.
Keywords: Patellar tendinitis, Jumper’s knee, MRI, Prognosis, Outcome, Return to sports
Background
Anterior knee pain and tenderness of the proximal patel-
lar tendon insertion site are frequently described charac-
teristics of patellar tendinopathy (PT) [4, 29]. Given its
high prevalence in jumping sports, Blazina et al. [4] in-
troduced the term of “jumper’s knee” as a synonym for
PT. The overall prevalence of PT yields 14% in national
elite athletes and increases up to 30 to 45% in high-risk
sports such as basketball and volleyball [10, 17, 19].
Reduced muscular flexibility has been determined as an
intrinsic risk factor for PT in athletes [2, 41]. Additionally,
PT is commonly observed in older and obese patients as
well as in subjects exhibiting an increased vastus medialis
muscle size [9, 33, 34]. Some investigators believe that the
inferior pole of the patella has a propensity to impinge
upon the deep surface of the proximal patellar tendon
during knee flexion [14, 21, 33]. It is assumed, that a
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longer non-articular inferior patellar pole might be a risk
factor for the onset of PT. On the contrary, Schmid and
co-workers found identical biometric relationships when
comparing tendon-patella-dimensions in symptomatic
and asymptomatic individuals and therefore rather
consider chronic overload than bony impingement as
the origin of pain [32]. Furthermore, Culvenor et al.
[7] demonstrated that an increased infrapatellar Hoffa
fat pad (IFP) might potentially contribute to the
pathogenesis of PT.
Beside patient history and clinical findings, ultrasonog-
raphy, conventional radiographs, and MRI are routinely
used for the diagnosis of PT as well as exclusion of con-
comitant pathologies [14, 28, 38]. Typical MRI findings
in PT are bone marrow edema (BME) of the inferior pa-
tellar pole, thickening of the proximal patellar tendon,
abnormal signal intensity of the proximal patellar ten-
don, infrapatellar bursitis, and hypertrophy as well as
IFP edema [5, 7, 18, 27, 28, 33]. Both, open and arthro-
scopic surgical treatment proved to be effective as
treatment for chronic-refractory PT unresponsive to
non-operative approaches [20]. Nowadays, arthroscopic
techniques are favored due to less invasiveness and fas-
ter rehabilitation [22, 23, 30].
While the pathogenesis and risk factors of PT are well
understood, evidence on factors predictive of postopera-
tive outcome are lacking [37]. We hypothesized, that
certain preoperative MRI findings may have prognostic
value for postoperative outcome in patients undergoing
arthroscopic treatment of chronic PT. Such knowledge
would allow for improved estimation of postoperative
functional and clinical outcome as well as time required
for return to sports. Consequently, therapeutic manage-
ment guided by prognostic factors could potentially
translate into optimized and accelerated treatment and
rehabilitation of athletes.
The aim of the present study was to analyze the prog-
nostic value of morphologic MRI parameters for the
clinical and functional outcome of competitive athletes
undergoing arthroscopic treatment due to chronic PT
unresponsive to non-operative therapy [25]. Therefore,
we quantified preoperative MRI findings specific for




This study was approved by the Ethics Committee of the
University of Freiburg (Vote-Nr.: 584/16). All participat-
ing patients provided written informed consent. Between
07/2005 and 03/2011, a prospective, prognostic cohort
study was performed on patients undergoing arthro-
scopic patellar release (APR) due to chronic-refractory,
symptomatic PT. Inclusion criteria were: age > 18 years,
competitive athlete, operative treatment by means of
APR, chronic-refractory, symptomatic PT despite a
minimum period of 6 months of non-operative treat-
ment, and a postoperative follow-up period > 2 years.
Patients displaying abnormal signal intensity indicating
partial rupture of the proximal patellar tendon and con-
comitant intra- or extra-articular knee joint pathologies
(e.g., patellofemoral malalignment/maltracking, chondral
lesions >1° according to the International Cartilage
Repair Society, meniscal tears and ligamentous injuries)
were excluded. Further exclusion criteria were impair-
ment of sports performance and/or sports cessation for
reasons other than symptomatic PT (e.g. secondary in-
juries of the affected extremity), incompliance and use of
doping agents. All patients were referred to our institu-
tion for operative treatment due to failed conservative
treatment. Non-operative measures consisted of eccen-
tric physiotherapy for a minimum period of 3 months,
oral non-steroidal anti-inflammatory drugs, extracorpor-
eal shockwave treatment and up to 3 ultrasound-guided
peritendinous corticosteroid injections. The first author
(PO) performed all surgeries using an identical operative
technique and postoperative rehabilitation program as
described previously [25].
A total of 29 patients were eligible for study participa-
tion, and all of them could be included. After study in-
clusion, one patient had to be excluded due to an
ipsilateral ankle fracture resulting in a permanent re-
striction of function. Follow-up examinations were com-
pleted in 28 patients (96.6%). Two male athletes were
operated bilaterally corresponding to a total of 30 cases.
Sports involved were running (n = 10), soccer (n = 8),
handball (n = 4), alpine skiing (n = 3), cycling (n = 2), and
body building (n = 1). None of the athletes experienced
an injury of the index knee prior to surgery.
Preoperative diagnostics
Preoperatively, one experienced orthopedic surgeon ob-
tained medical histories and performed standardized
clinical examination of all knee joints. Radiological diag-
nostics included plain radiographs (anteroposterior and
lateral knee views, axial patellofemoral views), ultrason-
ography and magnetic resonance imaging (MRI) of the
affected knee joints to exclude intra- and extraarticular
co-pathologies.
Preoperative MRI evaluation
All MRI examinations were performed according to the
guidelines of the German Medical Association and German
Roentgen Society. The detailed MRI protocol is displayed
in Table 1.
Proton density-weighted spin-echo sequences with
spectral fat saturation were acquired without administra-
tion of contrast agents.
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Preoperative MRI evaluation of the patellar tendon
and surrounding tissues were conducted utilizing T1,
T2, and proton density-weighted sequences [24–26].
Echo times were ranging between 33 ms and 40 ms to
avoid “magic-angle” artifacts [15]. Knee MRIs were
assessed by an independent senior radiologist having
profound knowledge of MRI changes associated with
PT. Standardized MRI evaluation included assessment of
the following criteria: 1.) BME of the inferior patellar
pole (Fig. 1a), 2.) IFP edema (Fig. 1c/d), 3.) infrapatellar
bursitis (Fig. 1c/d) and 4.) thickening of the proximal
patellar tendon (Fig. 1b).
BME of the inferior patellar pole was defined as distinct,
focal enhancement compared to a normal surrounding
bone signal. Accordingly, IFP edema was identified, if the
signal intensity of the IFP revealed a clearly detectable in-
crease compared to normal fat tissue. Infrapatellar bursitis
was defined as pathological fluid collection within the
infrapatellar bursa. Thickening of the patellar tendon was
noted, if the patellar tendon’s proximal portion displayed a
non-harmonic swelling compared to the distal part of the
tendon, exceeding an AP-diameter > 7 mm [5, 18, 27, 28,
38].
Outcome measures
Standardized follow-up examinations were performed by
an independent senior orthopaedic resident. The vali-
dated German version of the VISA-P score (0–100
points) and the modified Blazina score according to
Ferretti et al. [11] served as functional outcome scores
[20]. The modified Blazina score represents a pathology-
specific outcome measure comprising five stages accord-
ing to symptoms occurring at different level of sports/
activity (0 = no pain, 1 = pain after intense sports activity,
2 = pain at beginning of and after sports activity, 3 = pain
during activity at a satisfactory level, 4 = pain during
sports activity at an non-satisfactory level, and 5 = pain
during daily activity. Athletes rated the subjective func-
tion of the affected knee by means of single assessment
numeric evaluation (SANE), as determined by the writ-
ten response to the following question: On a scale from
zero to 100, how would you rate your knee today (100
being normal) [40]?
Additionally, patients were advised to document their
maximum pain level during activity on a visual analog
scale (VAS). Postoperatively, the number of months was
quantified until athletes were able to perform specific
exercises without any or minimal pain as defined by
Kelly et al. [16]. At follow-up, each athlete was asked to
assess his symptoms and level of sports performance
compared to before injury.
Statistics
Statistical analysis was performed using the software
SAS, version 9.3 (SAS Institute, Cary, North Carolina,



















1 Sagittal proton density-
weighted sequence
3000-4070/33,5-40 10 42 200 512 × 512 2 3.0 3.3
2 Axial proton density-
weighted sequence
3550/33 10 25 180 1024 × 1024 1 3.0 3.3
3 Coronal proton density-
weighted sequence
3000-4070/33,5-40 10 42 180 1024 × 1024 2 3.0 3.3
4 Sagittal T1 weighted
sequence
400/14,7 6 21 180 512 × 512 2 3 3.2
Fig. 1 Specific MRI findings in chronic PT: a BME of the inferior patellar
pole, b thickening of proximal patellar tendon, c/d IFP edema
with infrapatellar bursitis
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USA). Descriptive results are given as mean values with
standard deviations (±) and/or ranges. A non-parametric
Wilcoxon test was used to compare subgroups of pa-
tients with negative and positive MRI findings, respect-
ively. Categorical parameters were analyzed with the
exact Fisher test. Statistical significance was considered
for p-values < 0.05.
Results
Clinical outcome
There were no perioperative or surgical complications.
One senior orthopedic surgeon performed clinical exam-
ination on the first postoperative day prior to discharge.
All athletes stated relief of their previous sharp and cir-
cumscribed pain around the inferior patellar pole. They
were already able to perform a one-legged stance and
some light squats without experiencing their previous
characteristic pain of PT.
Outcome scores
At follow-up, all outcome measures showed significant
improvements compared to their preoperative values.
The VISA-P score increased from a preoperative mean
value of 55.6 points (±12.4 points) to a mean follow-up
value of 95.4 points (±8.1 points; p < 0.0001). Twenty-
one (70.0%) cases achieved the full VISA-P score of 100
points. Overall, 22 (73.3%) cases achieved excellent (91
to 100 points), 7 (23.3%) cases good (81 to 90 points) re-
sults, and one (3.3%) patient an unsatisfactory (70
points) outcome according to the VISA-P score.
The mean modified Blazina score decreased from 4.1
points (±0.77 points) to 0.3 points (±0.60 points; p <
0.0001). Twenty-three (76.7%) cases experienced no pain
at all (0 points), 5 (16.7%) felt minor to moderate pain
after intense sports activity (1 point) and 2 (6.7%) had
pain at the beginning of and after sports activity (2
points).
Likewise, patients experienced a significant improve-
ment of their subjective knee function indicated by an
increase of SANE score from 45.2 ± 17.5 preoperatively
to 90.2 ± 11.4 at last follow-up (p < 0.0001). Fourteen
(46.7%) patients rated their subjective knee function as
excellent (91 to 100), 12 (40.0%) as good (81 to 90), 2
(6.7%) as satisfactory (71 to 80), and 2 (6.7%) as still un-
satisfactory with a score of 70 in both cases. Still, both
patients were able to perform sports at their preinjury
competition level.
Moreover, the mean preoperative pain level according to
VAS decreased from 5.7 (±1.30) to 0.5 (±1.01; p < 0.0001) at
follow-up.
Return to sports
The mean time period required for return to sports was
4.0 months (±3.2 months; range, 0.5- 12 months). At
follow-up, all athletes were able to perform at their pre-
injury, competitive sports level. Twenty-three (76.7%)
cases did not experience any symptoms during or after
sports activity. Five (16.7%) athletes felt minor to moder-
ate pain after intense sports performance. The two
(6.7%) athletes with an unsatisfactory subjective result
complained about notable pain at the onset of and/or
after sports competition. However, both were able to
compete in sports at their previous level and local symp-
toms were less distinct.
MRI findings
Pathological thickening of the proximal patellar tendon
(Fig. 1b) was noted in all cases. Four cases displayed
infrapatellar bursitis with pathological fluid collection
(Fig. 1c/d). Table 2 summarizes sports, age and MRI
findings specific for chronic PT for all 30 cases.
Bone marrow edema
Preoperatively, BME of the inferior patellar pole was
present in 17/30 (56.7%) cases and absent in 13/30
(43.3%) cases. Patients presenting a BME were not asso-
ciated with impaired clinical or functional outcome at
the last follow-up (p > 0.05). Table 3 shows specific pro-
files and outcomes for both groups.
Infrapatellar fat pad edema
IFP edema was detected in 10/30 (33.3%) of cases on
preoperative MRI. Patients with IFP edema had a signifi-
cantly lower mean VISA-P score and subjective knee
function (SANE) preoperatively compared to unaffected
subjects. At the last follow-up, presence of IFP edema
was associated with significantly inferior clinical out-
come by means of modified Blazina score, SANE and
VAS and also longer return to sports periods (6.5 vs.
2.8 months) compared to patients without IFP edema.
Table 4 shows group-specific profiles and outcomes of
patients with and without IFP edema.
Simultaneous bone marrow edema and infrapatellar fat
pad edema
A proportion of 7/30 (23.3%) cases simultaneously
showed both BME and IFP edema, whereas 13/30
(43.3%) cases only displayed an isolated edema (BME or
IFP edema). Patients having such combined edemas had
a significantly lower mean preoperative VISA-P score
compared to patients with an isolated edema. At follow-
up, simultaneous presence of BME and IFP was associ-
ated with significantly inferior functional and clinical
outcome by means of VISA-P, SANE and VAS score
compared to subjects with an isolated edema. Though,
the mean time required for return to sports did not dif-
fer significantly. Table 5 shows group-specific profiles
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and outcomes of cases with combined edemas compared
to cases with an isolated edema.
Discussion
This prospective cohort study identified specific pre-
operative MRI findings serving as prognostic outcome
factors in arthroscopic treatment of chronic PT.
Preoperative IFP edema was associated with significantly
inferior outcomes related to the modified Blazina score,
subjective knee function (SANE) and VAS. All athletes
returned to their preinjury, competitive sports levels
after a mean of 4.0 months (±3.2 months). Return to
sports was significantly delayed in athletes with pre-
operative IFP edema (6.5 versus 2.8 months). Moreover,
coexistence of BME and IFP edema showed significantly
inferior outcomes related to the VISA-P score, SANE
and VAS compared to singular edema (BME or IFP), but
did not prolong time required for return to sports.
Multiple studies focused on risk factors of PT [9, 34,
37, 41]. However, no previous study identified evidence-
based prognostic outcome factors. Current study found
preoperative IFP edema to be a determinant prognostic
factor being associated with inferior functional outcomes
and prolongation of return to sports. This finding sup-
ports the current understanding towards the contribu-
tion of peritendinous soft tissue, such as tenosynovium
and IFP to the pathogenesis of chronic PT [7, 12, 13, 26,
31, 36]. With respect to the patellar tendon, the IFP
Table 2 Basic demographics and case-related MRI findings
Case Sports Age BME Tendon Thickening IFP Edema Infrapatellar Bursitis
1 Running 30 yes yes yes no
2 Soccer 23 yes yes yes no
3 Handball 29 no yes no no
4 Handball 28 no yes no no
5 Alpine skiing 19 yes yes no no
6 Soccer 22 yes yes no no
7 Cycling 33 yes yes no no
8 Handball 19 no yes no no
9 Soccer 30 no yes no no
10 Running 34 yes yes yes no
11 Running 49 no yes yes no
12 Running 39 yes yes no no
13 Hammer Throw 24 yes yes no no
14 Running 43 yes yes yes yes
15 Soccer 30 no yes yes yes
16 Body Building 43 no yes no no
17 Soccer 23 yes yes yes no
18 Handball 19 yes yes no no
19 Soccer 20 no yes no no
20 Running 31 yes yes no yes
21 Running 29 no yes no no
22 Running 41 no yes no yes
23 Alpine Skiing 20 yes yes no no
24 Running 21 no yes no no
25 Cycling 39 yes yes yes no
26 Soccer 21 yes yes yes no
27 Soccer 27 yes yes no no
28 Alpine Skiing 24 yes yes no no
29 Running 34 no yes no no
30 Running 22 no yes yes no
Total cases with positive MRI 17 30 10 4
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effects stress distribution at the enthesis and provides
relevant neurovascular supply [3, 12, 26]. Moreover, the
IFP is known to trigger complex pathophysiologic and
biochemical processes in response to osteoarthritis and
other acute and chronic disorders of the knee joint
[13, 36]. PT involves a complex interaction of extrin-
sic and intrinsic processes. Chronic mechanical over-
load is supposed to cause microinjuries of the patellar
tendon enthesis which ultimately leads to an inflam-
matory reaction of the surrounding soft tissues pro-
moting neovascularization, nerve ingrowth into the
proximal patellar tendon, and increased pain sensa-
tion [1, 7, 8, 18, 31, 35, 36]. In the present study, this
pathologic cycle of metabolic and proinflammatory al-
terations was represented by IFP edema and BME
assessed by MRI examinations and resulted in inferior
pre- and postoperative function, higher pain levels
and longer periods of postoperative recovery [13, 36].
Furthermore, our findings confirm MRI observations
by Culvenor and Warden et al. [7, 38] who detected
associations between MRI-based IFP abnormalities
and clinical symptoms and proposed that a hyper-
trophic IFP would promote the perception and recal-
citrance of pain. In the study of Warden et al. [38] a
proportion of 13/30 (43.3%) symptomatic patients
showed IFP signal alterations indicating an edematous
reaction. These findings correspond well to ours with
10/30 (33.3%) cases presenting an IFP edema.
The procedure of APR focuses on causative treatment
of peritendinous soft tissue pathologies (IFP, tenosyno-
vitis) without performing any tendon or bone resection
[25]. Present study shows, that APR as a minimal-
invasive soft tissue procedure yields favorable results
which are equivalent to more invasive (arthroscopic or
open) procedures involving tendon and/or bone resec-
tion [6, 22, 24]. These findings are confirmed by the
study of Willberg et al. [39], who performed arthro-
scopic shaving in order to address neovascularization
Table 3 Outcome analysis related to presence of BME
BME present BME absent P-Value
Case Number [n, (%), total n = 30] 17 (56.7%) 13 (43.3%)
Mean Age at Surgery [years] 27.4 (±8.0) 29.3 (±8.5) P = 0.570
Mean Follow-up [years] 3.2 (±1.3) 5.3 (±3.8) P = 0.107
VISA-P score preop. [points] 53.9 (±12.5) 58.8 (±12.7) P = 0.308
VISA-P score postop. [points] 94.1 (±9.6) 97.2 (±5.3) P = 0.327
Mod. Blazina score preop. [points] 4.0 (±0.9) 4.2 (±0.6) P = 0.672
Mod. Blazina score postop. [points] 0.4 (±0.7) 0.2 (±0.4) P = 0.335
Subjective Knee Function (SANE) preop. 44.7 (±18.2) 45.4 (±18.0) P = 0.833
Subjective Knee Function (SANE) postop. 90.0 (±10.6) 93.5 (±5.2) P = 0.617
Pain (VAS) preop. 5.7 (±1.4) 5.8 (±1.2) P = 0.949
Pain (VAS) postop. 0.7 (±1.2) 0.2 (±0.6) P = 0.226
Mean Time Period for Return to Sports [months] 4.1 (±3.2) 3.9 (±3.3) P = 0.780
Table 4 Outcome analysis related to presence of IFP edema
IFP edema present IFP edema absent P-Value
Case Number [n, (%), total n = 30] 10 (33.3%) 20 (66.7%)
Mean Age at Surgery [years] 30.9 (±10.4) 26.9 (±6.6) P = 0.270
Mean Follow-up [years] 3.5 (±1.5) 4.5(±3.4) P = 0,555
VISA-P score preop. [points] 48.3 (±9.4) 59.9(±12.3) P = 0.024*
VISA-P score postop. [points] 91.7 (±11.3) 97.3 (±5.3) P = 0.184
Mod. Blazina score preop. [points] 4.4 (±0.7) 3.9 (±0.8) P = 0.106
Mod. Blazina score postop. [points] 0.6 (±0.7) 0.2 (±0.5) P = 0.024*
Subjective Knee Function (SANE) preop. 33.5 (±16.0) 50.8 (±16.0) P = 0.016*
Subjective Knee Function (SANE) postop. 86.0 (±8.8) 94.3 (±7.5) P = 0.009*
Pain (VAS) preop. 6.5 (±1.5) 5.4 (±1.0) P = 0.054
Pain (VAS) postop. 1.0 (±1.2) 0.3 (±0.8) P = 0.009*
Mean Time Period for Return to Sports [months] 6.5 (±3.8) 2.8 (±2.0) P = 0.003*
*: indicates statistical significance with P< 0.05
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and neoinnervation adjacent to the tendinopathic
changes on the posterior aspect of the tendon. Spur
formation and/or increased extension of the inferior
patellar pole with secondary bony impingement used
to be regarded as a predominant pathogenetic factor
in PT. Consequently, many authors proposed inferior
patellar pole resection as a causative therapy. Though,
current research raises increasing doubts towards this
hypothesis [7, 32].
In clinical practice, knowledge of predictive MRI find-
ings could prove valuable for a more detailed risk strati-
fication and prognosis of outcome especially in patients
with high functional demands such as competitive ath-
letes. Additionally, prognostic factors can serve for the
purpose of individualized treatment and rehabilitation
concepts potentially resulting in improved clinical out-
come. In the present study, athletes needed 4 months on
average to return to competitive sports levels. We as-
sume that chronic muscular and kinematic disorders
may have additionally contributed to the prolongation of
postoperative rehabilitation. In our experience, athletes
should refrain from sports for at least 3 months after
APR. A too progressive rehabilitation might promote
(partial) persistence, prolongation, and/or recurrence of
symptoms. Results of current research enable the potential
for novel therapeutic approaches. Specific conservative
treatment for IFP edema might accelerate postoperative
rehabilitation and improve clinical outcome following
arthroscopic treatment of PT.
A few limitations need to be considered. We ruled out
patients with signal alterations of the proximal patellar
tendon since partial tendon rupture could not be reliably
excluded. Thus, present findings only apply to patients
with structurally intact patellar tendons. Additionally,
the present study design did not appreciate the potential
influence of IFP volume within a sub-analysis as
demonstrated previously [7]. Postoperative MRIs were
not performed routinely, and thus could not be analyzed
for follow-up assessment. Furthermore, the relatively
small study population did not allow a sports-specific
sub-analysis. These issues need to be addressed in future
studies analyzing the causes of IFP edema (i.e. type of
sport, level of competition, modality of conservative
treatment, comorbidity, and duration of symptoms).
However, to our best knowledge, there exists no previ-
ous study focusing on prognostic outcome factors in
arthroscopic treatment of PT.
Conclusions
This is the first study identifying prognostic outcome
factors in arthroscopic treatment of chronic PT. Pre-
operative IFP edema alone or IFP edema and concomi-
tant BME on preoperative MRI were associated with
inferior functional outcome and delayed return to sports.
Current findings emphasize the pathogenetic importance
of peritendinous soft tissue involvement in chronic
symptomatic PT being effectively addressed by the
minimal-invasive technique of APR without performing
bone or tendon resection. Knowledge of these predictive
factors might improve risk stratification, individualize
treatment and postoperative rehabilitation, and contrib-
ute to improve clinical outcome. Moreover, current find-
ings offer the potential for novel therapeutic approaches.
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Table 5 Outcome analysis related to simultaneous presence of BME and IFP edema
BME and IFP edema present BME or IFP edema present P-Value
Case Number [n, (%), total n = 30] 7 (23.3%) 13 (43.3%)
Mean Age at Surgery [years] 29.7 (±9.7) 27.6 (±8.8) P = 0.578
Mean Follow-up [years] 3.3 (±1.4) 3.3 (±1.5) P = 0.888
VISA-P score preop. [points] 46.0 (±7.8) 58.1(±12.1) P = 0.043*
VISA-P score postop. [points] 88.1 (±11.9) 98.6 (±4.2) P = 0.028*
Mod. Blazina score preop. [points] 4.4 (±0.8) 3.8 (±0.9) P = 0.176
Mod. Blazina score postop. [points] 0.7 (±0.8) 0.2 (±0.6) P = 0.085
Subjective Knee Function (SANE) preop. 35.0 (±15.5) 46.5 (±19.5) P = 0.197
Subjective Knee Function (SANE) postop. 84.3 (±10.2) 93.1 (±8.3) P = 0.049*
Pain (VAS) preop. 6.4 (±1.4) 5.5 (±1.5) P = 0.181
Pain (VAS) postop. 1.3 (±1.4) 0.3 (±0.9) P = 0.022*
Mean Time Period for Return to Sports [months] 5.9 (±3.2) 4.1 (±3.9) P = 0.071
*: indicates statistical significance with P< 0.05
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